| 영문 | beta human chorionic gonadotropin | 한글 | 베타 사람융모성 생식샘자극호르몬 |
|---|---|---|---|
| 설명 | 태반세포에서 만들어지는 호르몬. 기능은 임신의 초기에 황체(원래 난자를 싸고 있던 세포들이 배란이 일어나서 난자가 빠져나간 후 주머니 모양을 이룬 것. 임신초기에 임신의 유지에 필요한 호르몬을 생성한다)의 유지에 기여하고, 태아의 고환조직에서 남성호르몬이 분비되는 것을 촉진시킨다. 또 이것은 임신초기의 임산부의 소변에서 많은 양이 검출되므로 이것을 이용해서 임신의 여부를 손쉽게 조사할 수가 있다. |
||
| DHR | delayed hypersensitivity reaction; Department of Human Resources |
|---|---|
| HRA | health record analyst; health risk appraisal; heart rate audiometry; hereditary renal adysplasia; hi... |
| HPL | human parotid lysozyme; human peripheral lymphocyte; human placental lactogen |
| AAHC | American Academy of Healthcare Consultants; Association of Academic Health Centers |
| ACHE | American College of Healthcare Executives; American Council for Headache Education |
| ACHS | Australian Council of Healthcare Standards |
|---|---|
| HRSA | Health Resources and Services Administration |
| JCAHO | Joint Commission of Accreditation of Healthcare Organizations |
| OARS | Older American Resources and Services |
| HMG/HCG | human menopausal gonadotrophin/human chorionic gonadotropin |
| joint commission on accreditation of healthcare organizations | A private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation. (12 Dec 1998) |
|---|---|
| conservation of energy resources | Planned management, use, and preservation of energy resources. (12 Dec 1998) |
| conservation of natural resources | The protection, preservation, restoration, and rational use of all resources in the total environment. (12 Dec 1998) |
| health resources | Available manpower, facilities, revenue, equipment, and supplies to produce requisite health care and services. (12 Dec 1998) |
| energy-generating resources | Natural energy sources of power supply. (12 Dec 1998) |
| united states health resources and services administration | A component of the public health service that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training. (12 Dec 1998) |
| adenoviruses, human | Species of the genus mastadenovirus, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. (12 Dec 1998) |
| adenovirus infections, human | Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses. (12 Dec 1998) |
| antigens, human platelet | Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. (12 Dec 1998) |
| bites, human | Bites inflicted by humans. (12 Dec 1998) |
| bonding, human-pet | The emotional attachment of individuals to pets. (12 Dec 1998) |
| packed human blood cells | Whole blood from which plasma has been removed; may be prepared any time during the dating period of the whole blood from which it is derived, but not later than six days after the blood has been drawn if separation of plasma and cell's is achieved by centrifugation. (05 Mar 2000) |
| papilloma virus, human | A family of over 60 viruses responsible forcausing warts. The majority of the viruses produce warts on the hands, fingers, and even the face. most of these viruses are innocuous, causing nothing more than cosmetic concerns. Several types of HPV are confined primarily to the moist skin of the genitals, producing genital warts and elevating the risk for cancer of the cervix. These viruses that cause wartlike growths on the genitals and contrribute to cancer of the cervix are sexually transmitted. (12 Dec 1998) |
| parainfluenza virus 1, human | The type species of paramyxovirus also called haemadsorption virus 2 (ha2), which causes laryngotracheitis in humans, especially children. (12 Dec 1998) |
| parainfluenza virus 2, human | A species of rubulavirus associated particularly with acute laryngotracheitis (croup) in children aged 6 months to 3 years. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|